These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7215531)

  • 1. Quantitative analysis of ceruletide in the drug substance and in the pharmaceutical preparations by high performance liquid chromatography.
    Raja B; de Castiglione R; Vigevani A
    Farmaco Prat; 1981 Feb; 36(2):89-98. PubMed ID: 7215531
    [No Abstract]   [Full Text] [Related]  

  • 2. HPLC method for quantitative determination of synthetic ceruletide and its impurities.
    Franzoi L; Gioia B; de Castiglione R; Vigevani A; Williamson MJ
    Farmaco Prat; 1988 Oct; 43(10):317-23. PubMed ID: 3234535
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quantitative analysis of morphine in pharmaceutical preparations by high performance liquid chromatography].
    Pierron C; Etcheverry MF; Panas JM; Ledouble G
    Ann Pharm Fr; 1987; 45(6):475-84. PubMed ID: 3504124
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of d-alpha-tocopherol and its impurity by chiral high performance liquid chromatography in pharmaceutical preparations.
    Kłaczkow G; Jakoniuk D; Anuszewska EL
    Acta Pol Pharm; 2004; 61(3):181-4. PubMed ID: 15481242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in using high performance liquid chromatography for drug analysis.
    Lurie IS
    J Forensic Sci; 1984 Apr; 29(2):607-10. PubMed ID: 6726165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ultra-performance liquid chromatography in pharmaceutical development.
    Wren SA; Tchelitcheff P
    J Chromatogr A; 2006 Jun; 1119(1-2):140-6. PubMed ID: 16564533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of dl-methylephedrine hydrochloride and noscapine in mixed pharmaceutical preparations by high performance liquid chromatography-autoanalyser system separation].
    Ejima A; Tatsuzawa M; Matsuda R; Takai N
    Eisei Shikenjo Hokoku; 1983; (101):1-6. PubMed ID: 6675749
    [No Abstract]   [Full Text] [Related]  

  • 9. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel collagenase-assisted extraction of active pharmaceutical ingredients from gelatin products for quantitative analysis by high performance liquid chromatography.
    Zhao C; Furukawa S; Ohki Y
    J Chromatogr A; 2009 May; 1216(20):4524-8. PubMed ID: 19344904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the stereoisomers of racemic alpha-tocopherol in pharmaceutical preparations by high-performance liquid chromatography and gas chromatography.
    Kłaczkow G; Anuszewska EL
    Acta Pol Pharm; 2008; 65(6):715-21. PubMed ID: 19172854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ultra-high performance supercritical fluid chromatography and ultra-high performance liquid chromatography for the analysis of pharmaceutical compounds.
    Grand-Guillaume Perrenoud A; Veuthey JL; Guillarme D
    J Chromatogr A; 2012 Nov; 1266():158-67. PubMed ID: 23092872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis.
    Beilin E; Baker LJ; Aikins J; Baryla NE
    J Pharm Biomed Anal; 2010 Jun; 52(2):316-9. PubMed ID: 20116957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona CAD detector.
    Huang Z; Richards MA; Zha Y; Francis R; Lozano R; Ruan J
    J Pharm Biomed Anal; 2009 Dec; 50(5):809-14. PubMed ID: 19616396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of steroid acetates in pharmaceutical preparations by high performance liquid chromatography.
    van Dame HC
    J Assoc Off Anal Chem; 1980 Nov; 63(6):1184-8. PubMed ID: 7451381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-performance liquid column chromatography of drugs].
    Macek K; Deyl Z
    Cesk Farm; 1977 Nov; 26(9):420-9. PubMed ID: 608207
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
    Yu K; Little D; Plumb R; Smith B
    Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern HPLC in drug analysis].
    Hudecová T; Tekeĺ J; Havránek E
    Ceska Slov Farm; 2003 Mar; 52(2):55-67. PubMed ID: 12754925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic drug monitoring by high-performance liquid chromatography (author's transl)].
    Goto J
    Rinsho Byori; 1982 Apr; 30(4):384-9. PubMed ID: 7098071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.